Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
LHDX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
marketbeat.com
6 hours ago
pennystocks.com
6 hours ago
investorplace.com
8 hours ago
investorplace.com
9 hours ago
proactiveinvestors.com
10 hours ago
pennystocks.com
12 hours ago
Earnings Growth
YoY
Current
Estimates
Q2.20
N/A
NA
vs NA
Q3.20
N/A
NA
vs NA
Q4.20
N/A
-0.26
vs -0.14
Q1.21
N/A
-0.54
vs -0.11
Q2.21
N/A
-0.38
vs -0.43
Q3.21
N/A
-0.47
vs -0.77
Q4.21
+104%
0.01
vs -0.26
Q1.22
+157%
0.31
vs -0.54
Q2.22
N/A
-0.54
vs -0.38
Q3.22
N/A
-3.15
vs -0.47
Sales Growth
YoY
Current
Estimates
Q2.20
NA
NA vs NA
Q3.20
NA
NA vs NA
Q4.20
NA
269K vs NA
Q1.21
NA
4.5M vs NA
Q2.21
NA
12.4M vs NA
Q3.21
NA
15M vs NA
Q4.21
+22623%
61.1M vs 269K
Q1.22
+1903%
90.5M vs 4.5M
Q2.22
+110%
26.1M vs 12.4M
Q3.22
+130%
34.4M vs 15M
Return on Equity
QoQ
Q2.20
NA
NA
vs NA
Q3.20
+26%
0.26
vs NA
Q4.20
+28%
0.28
vs 0.26
Q1.21
-6%
-0.06
vs 0.28
Q2.21
-8%
-0.08
vs -0.06
Q3.21
-14%
-0.14
vs -0.08
Q4.21
-4%
-0.04
vs -0.14
Q1.22
+6%
0.06
vs -0.04
Q2.22
-12%
-0.12
vs 0.06
Q3.22
-208%
-2.08
vs -0.12
Institutionnal Ownership
QoQ
Q3.21
39
39
vs 44
-11%
Q4.21
49
49
vs 39
26%
Q1.22
39
39
vs 49
-20%
Q2.22
38
38
vs 39
-3%
Q3.22
27
27
vs 38
-29%
Q4.22
27
27
vs 27
NA
Q1.23
6
6
vs 27
-78%
Q2.23
1
1
vs 6
-83%
Q3.23
NA
NA
vs NA
NA
Q4.23
1
1
vs NA
NA
Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Buy
Price Target
N/A(N/A)
Number of analyst
N/A
Last analyst upgrade/downgrade
No Data Available
Quote Panel
Key Metrics
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California.
NASDAQ
Unprofitable
Unprofitable
Relative Strenght
20
Volume Buzz
69%
Earning Acce
No
Dist 52w H.
90%Relative Strength
LHDX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How LHDX compares to sector?
LHDX
0x